Medicare Enrolled
Dr. Rajan Goyal, M.D.
Critical Care Medicine · Bakersfield, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Goyal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goyal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Goyal
Dr. Rajan Goyal is a critical care medicine specialist in Bakersfield, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Goyal performed 3,183 Medicare services across 1,697 unique beneficiaries.
Between the years covered by Open Payments, Dr. Goyal received a total of $11,183 from 52 pharmaceutical and/or device companies across 601 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Goyal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 8% volume in CA
$11,183 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,183
Medicare services
Top 8% in CA for critical care medicine
1,697
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~177 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,075 | $133 | $345 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
283 | $167 | $552 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
254 | $1 | $10 |
| New patient office visit, complex (60-74 min) | 229 | $164 | $432 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
182 | $74 | $158 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
179 | $0 | $20 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
171 | $0 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
163 | $104 | $230 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
117 | $11 | $30 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
101 | $0 | $30 |
| Multiplex respiratory virus test (COVID-19, flu, RSV) A laboratory test that uses a multiplex amplified probe technique to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus types A and B, and respiratory syncytial virus (RSV). |
51 | $140 | $175 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
49 | $16 | $49 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
47 | $28 | $70 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
46 | $12 | $32 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
45 | $46 | $115 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
44 | $48 | $122 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
43 | $32 | $127 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
27 | $35 | $175 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
26 | $16 | $25 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
25 | $2 | $50 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
14 | $91 | $509 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $136 | $345 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,183
Total received (2018-2024)
Avg $1,598/year across 7 years
Top 13% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
601
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,496 (93.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$687 (6.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,635
2023
$1,525
2022
$1,297
2021
$1,491
2020
$1,332
2019
$2,362
2018
$1,541
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$367
AstraZeneca Pharmaceuticals LP
$201
Astellas Pharma US Inc
$188
Boehringer Ingelheim Pharmaceuticals, Inc.
$154
Regeneron Healthcare Solutions, Inc.
$143
Grifols USA, LLC
$81
Actelion Pharmaceuticals US, Inc.
$81
Mylan Specialty L.P.
$75
Merck Sharp & Dohme LLC
$62
Pulmonx Corporation
$61
Baxter Healthcare
$60
Bayer Healthcare Pharmaceuticals Inc.
$31
United Therapeutics Corporation
$25
Hikma Pharmaceuticals USA
$23
GENZYME CORPORATION
$21
Medtronic, Inc.
$21
Amgen Inc.
$20
Insmed, Inc.
$19
Top 3 companies account for 46.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,315
AstraZeneca Pharmaceuticals LP
$1,569
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,197
Actelion Pharmaceuticals US, Inc.
$856
Astellas Pharma US Inc
$711
Philips Electronics North America Corporation
$339
Novo Nordisk Inc
$291
Grifols USA, LLC
$287
Sunovion Pharmaceuticals Inc.
$267
United Therapeutics Corporation
$266
Pulmonx Corporation
$237
Janssen Pharmaceuticals, Inc
$215
Regeneron Healthcare Solutions, Inc.
$209
Bayer HealthCare Pharmaceuticals Inc.
$207
PFIZER INC.
$201
Novartis Pharmaceuticals Corporation
$188
Takeda Pharmaceuticals U.S.A., Inc.
$165
ADVANCED RESPIRATORY, INC
$133
Merck Sharp & Dohme LLC
$114
Mylan Specialty L.P.
$113
MAYNE PHARMA INC.
$101
Baxter Healthcare
$97
Medtronic, Inc.
$89
Bayer Healthcare Pharmaceuticals Inc.
$82
Genentech USA, Inc.
$82
Insmed, Inc.
$77
GENZYME CORPORATION
$72
Daiichi Sankyo Inc.
$71
Medtronic Vascular, Inc.
$63
Otsuka America Pharmaceutical, Inc.
$51
Allergan Inc.
$48
Merck Sharp & Dohme Corporation
$43
Covidien LP
$43
LivaNova USA, Inc.
$37
Boston Scientific Corporation
$30
Electromed, Inc.
$29
Ironwood Pharmaceuticals, Inc
$28
Harmony Biosciences LLC
$23
Hikma Pharmaceuticals USA
$23
Horizon Therapeutics plc
$23
Avanir Pharmaceuticals, Inc.
$21
Pinnacle Biologics, Inc
$20
Amgen Inc.
$20
La Jolla Pharmaceutical Company
$18
Veran Medical Technologies, Inc.
$16
Shire North American Group Inc
$16
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
Allergan, Inc.
$14
Phadia US Inc.
$14
Lilly USA, LLC
$13
Circassia Pharmaceuticals Inc
$13
Egalet US Inc
$13
Top 3 companies account for 45.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Advisa · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CHARTIS CATHETER · CRESEMBA · Cresemba · DORYX · DUPIXENT · DUZALLO · ELIQUIS · Esbriet · FASENRA · GIAPREZA · GLASSIA · Hemolung Cartridge Kit · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · ILLUMISITE · INJECTAFER · INVOKANA · ImmunoCAP · JARDIANCE · LONHALA MAGNAIR · Linzess · Motegrity · NUCALA · NUEDEXTA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PAXLOVID · PENNSAID · Perforomist · Photofrin · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · RADICAVA · REXULTI · Ryaltris · Rybelsus · S&RC Und · SAMSCA · SMARTVEST · SPIRIVA RESPIMAT · SPRIX · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Spin · SuperDimension · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Tresiba · Trilogy 100 · Trintellix · UPTRAVI · WATCHMAN · WINREVAIR · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · YUPELRI · Yupelri · ZERBAXA · inCourage · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
5
Per 100K population
0.5
County median income
$67,660
Nearest hospital
BAKERSFIELD BEHAVIORAL HEALTHCARE HOSPITAL, LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Goyal is a clinical cardiology specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Goyal experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Goyal performed 1,075 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goyal receive payments from pharmaceutical companies?
Yes. Dr. Goyal received a total of $11,183 from 52 companies across 601 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goyal's costs compare to other critical care medicines in Bakersfield?
Dr. Goyal's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goyal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Bakersfield
Browse critical care medicines in Bakersfield ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in CA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in CA
Which CA critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology